from Laxxon Medical
Laxxon Medical to Participate in 25th Annual Needham Growth Conference
Laxxon Medical to Participate in 25th Annual Needham Growth Conference NEW YORK, NY / ACCESSWIRE / January 5, 2023 / Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023. Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital investors throughout the day on January 12, 2023. About Laxxon Medical Corporation Laxxon Medical is a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions through SPID®-Technology (Screen Printing Innovational Drug Technology), an additive 3D screen printing technology and manufacturing process. Laxxon Medical holds the exclusive worldwide rights to the use and application of SPID®-Technology for the development, manufacture, and commercialization of pharmaceutical dosage forms. For more information, visit www.laxxonmedical.com or follow Laxxon Medical on LinkedIn or Twitter. Investor Contact: Alexander Ruckdaeschel Media Contact: Frances Hoggard SOURCE: Laxxon Medical Corporation 01/05/2023 EQS Newswire / EQS Group AG |